Session 2 of Developments in Trauma Resuscitation and Management for EMS is led by Michael Carunchio. This ECHO session provides an overview of thoracic trauma, including its definition and epidemiology. It explores key mechanisms like deceleration injuries and cavitation, and highlights vulnerable structures such as the ligamentum arteriosum. The session reviews major injuries including pneumothorax, […]
Session 1 of Developments in Trauma Resuscitation and Management for EMS is led by Michael Carunchio. This ECHO session challenges the use of chest compressions in traumatic cardiac arrest, emphasizing that compressions without definitive interventions are ineffective and may be harmful. Instead, it reframes traumatic arrest as primarily obstructive or hemorrhagic, prioritizing interventions like relieving […]
Session 7 of Obesity Management is led by Kristen Mach. See bottom of description for accreditation info. This ECHO session explores the complex relationship between obesity and eating disorders. The session addresses myths vs. facts about weight, the limitations of BMI, the impact of weight stigma in healthcare, historical and scientific evidence on dieting and starvation, the […]
Session 8 of Obesity Management is led by Dr. Anshu Gupta. See bottom of description for accreditation info. This ECHO session explores the role of pharmacotherapy in the management of adolescent obesity. The session reviews the prevalence of pediatric obesity, highlights key guidance from the AAP pediatric obesity guidelines, and explores how anti-obesity medications can be […]
Session 4 of Novel and Emerging Technologies is led by Dr. Kat Fivelstad. This ECHO session explores the role of the EMS medical director and how evidence-based medicine informs EMS protocols and system improvements. Topics include the responsibilities of a medical director, how protocols are developed and changed, and how EMS providers can access and apply research […]
Read More… from Tactics for Changing Agency Protocols and Working with Med Directors
Session 3 of Novel and Emerging Technologies is led by Dr. Harrison Brookeman. This ECHO session explores the growing role of point-of-care ultrasound (POCUS) in emergency and prehospital care. It reviews why ultrasound is increasingly used in the field, key EMS applications such as identifying tamponade, hypovolemia, tension pneumothorax, thrombosis, and internal hemorrhage, and evidence […]
Session 1 of Novel and Emerging Technologies is led by Dr. Kat Fivelstad. This ECHO session explores advances in organ replacement technologies and disability accommodations, while also addressing the controversy surrounding ableism in healthcare. Topics include mechanical circulatory support devices and what EMS providers need to know about them, differences in treatments such as total artificial […]
Read More… from Bionic Patients: Encountering Wearables, Patient Monitoring, Treatment at Home
Session 2 of Novel and Emerging Technologies is led by Dr. Kat Fivelstad. This ECHO session explores emerging innovations shaping the future of emergency and prehospital care. Topics include heads-up CPR and prehospital whole blood transfusion initiatives, as well as new transportation tools such as drones for search and rescue, disaster response, and improving rural […]
Read More… from Emerging Innovations in EMS: AI, Drones, CPR, and Beyond
Session 10 of Obesity Management is led by Mary Lou Perry. See bottom of description for accreditation info. This ECHO session examines the growing popularity and clinical evidence behind intermittent fasting, particularly time-restricted eating (TRE). The session defines intermittent fasting and TRE, reviews key research findings, and compares time-restricted eating with continuous energy restriction approaches […]
Session 9 of Obesity Management is led by Dr. Jennifer Kirby. See bottom of description for accreditation info. This ECHO session focuses on understanding and managing the side effects associated with anti-obesity medications. The session reviews common gastrointestinal and non-gastrointestinal side effects patients may experience, including those related to incretin-based therapies, phentermine, and the bupropion/naltrexone […]
